Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information

Hitoshi Kawazoe, Tomomi Kubo, Naomi Iihara, Chiaki Doi, Makiko Okujyoh, Noriyasu Fukuoka, Satoshi Fujimoto, Nobuhiro Kanaji, Shuji Bandoh, Toshihiko Ishida, Yoshiharu Takiguchi, Hitoshi Houchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.

Original languageEnglish
Pages (from-to)629-642
Number of pages14
JournalYakugaku Zasshi
Volume126
Issue number8
DOIs
Publication statusPublished - 2006 Aug 11
Externally publishedYes

Fingerprint

Patient Participation
Information Dissemination
Drug Therapy
Neoplasms
Therapeutics
Pharmacists
Patient Care Team
Medical Staff
Communication
Anorexia
Nausea
Fatigue
Inpatients

Keywords

  • Cancer chemotherapy
  • Medical care team
  • Patient participation
  • Sharing patient information
  • Side effects monitoring

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information. / Kawazoe, Hitoshi; Kubo, Tomomi; Iihara, Naomi; Doi, Chiaki; Okujyoh, Makiko; Fukuoka, Noriyasu; Fujimoto, Satoshi; Kanaji, Nobuhiro; Bandoh, Shuji; Ishida, Toshihiko; Takiguchi, Yoshiharu; Houchi, Hitoshi.

In: Yakugaku Zasshi, Vol. 126, No. 8, 11.08.2006, p. 629-642.

Research output: Contribution to journalArticle

Kawazoe, H, Kubo, T, Iihara, N, Doi, C, Okujyoh, M, Fukuoka, N, Fujimoto, S, Kanaji, N, Bandoh, S, Ishida, T, Takiguchi, Y & Houchi, H 2006, 'Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information', Yakugaku Zasshi, vol. 126, no. 8, pp. 629-642. https://doi.org/10.1248/yakushi.126.629
Kawazoe, Hitoshi ; Kubo, Tomomi ; Iihara, Naomi ; Doi, Chiaki ; Okujyoh, Makiko ; Fukuoka, Noriyasu ; Fujimoto, Satoshi ; Kanaji, Nobuhiro ; Bandoh, Shuji ; Ishida, Toshihiko ; Takiguchi, Yoshiharu ; Houchi, Hitoshi. / Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information. In: Yakugaku Zasshi. 2006 ; Vol. 126, No. 8. pp. 629-642.
@article{ab466a8b18014a739d81e4e92f6a53f2,
title = "Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information",
abstract = "The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that {"}participation of pharmacists in cancer chemotherapy{"} was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.",
keywords = "Cancer chemotherapy, Medical care team, Patient participation, Sharing patient information, Side effects monitoring",
author = "Hitoshi Kawazoe and Tomomi Kubo and Naomi Iihara and Chiaki Doi and Makiko Okujyoh and Noriyasu Fukuoka and Satoshi Fujimoto and Nobuhiro Kanaji and Shuji Bandoh and Toshihiko Ishida and Yoshiharu Takiguchi and Hitoshi Houchi",
year = "2006",
month = "8",
day = "11",
doi = "10.1248/yakushi.126.629",
language = "English",
volume = "126",
pages = "629--642",
journal = "Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "8",

}

TY - JOUR

T1 - Monitoring the side effects of cancer chemotherapy with patients - The participation of patients in cancer therapy and sharing patient information

AU - Kawazoe, Hitoshi

AU - Kubo, Tomomi

AU - Iihara, Naomi

AU - Doi, Chiaki

AU - Okujyoh, Makiko

AU - Fukuoka, Noriyasu

AU - Fujimoto, Satoshi

AU - Kanaji, Nobuhiro

AU - Bandoh, Shuji

AU - Ishida, Toshihiko

AU - Takiguchi, Yoshiharu

AU - Houchi, Hitoshi

PY - 2006/8/11

Y1 - 2006/8/11

N2 - The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.

AB - The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that "participation of pharmacists in cancer chemotherapy" was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.

KW - Cancer chemotherapy

KW - Medical care team

KW - Patient participation

KW - Sharing patient information

KW - Side effects monitoring

UR - http://www.scopus.com/inward/record.url?scp=33746793252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746793252&partnerID=8YFLogxK

U2 - 10.1248/yakushi.126.629

DO - 10.1248/yakushi.126.629

M3 - Article

C2 - 16880721

AN - SCOPUS:33746793252

VL - 126

SP - 629

EP - 642

JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

SN - 0031-6903

IS - 8

ER -